Cytokinetics Inc. (CYTK)

11.14
0.09 0.80
NASDAQ : Health Technology
Prev Close 11.23
Open 11.21
Day Low/High 11.05 / 11.46
52 Wk Low/High 5.75 / 11.86
Volume 837.81K
Avg Volume 466.00K
Exchange NASDAQ
Shares Outstanding 57.72M
Market Cap 669.56M
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis

Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis

Data Monitoring Committee Recommends Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure to Continue Without Changes

First Week Of November 15th Options Trading For Cytokinetics (CYTK)

First Week Of November 15th Options Trading For Cytokinetics (CYTK)

Investors in Cytokinetics Inc saw new options become available this week, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Oversold Conditions For Cytokinetics (CYTK)

Oversold Conditions For Cytokinetics (CYTK)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CYTK Makes Bullish Cross Above Critical Moving Average

CYTK Makes Bullish Cross Above Critical Moving Average

In trading on Tuesday, shares of Cytokinetics Inc crossed above their 200 day moving average of $8.01, changing hands as high as $8.19 per share. Cytokinetics Inc shares are currently trading up about 0.9% on the day.

Netflix, Cytokinetics, Yeti Holdings: 'Mad Money' Lightning Round

Netflix, Cytokinetics, Yeti Holdings: 'Mad Money' Lightning Round

Jim Cramer weighs in on Netflix, Cytokinetics, Yeti Holdings, Kraft Heinz, Chico's, LyondellBasell Industries, DowDuPont and more.

CYTK Makes Bullish Cross Above Critical Moving Average

CYTK Makes Bullish Cross Above Critical Moving Average

In trading on Tuesday, shares of Cytokinetics Inc crossed above their 200 day moving average of $8.30, changing hands as high as $8.75 per share. Cytokinetics Inc shares are currently trading up about 13.7% on the day.

CYTK Makes Bullish Cross Above Critical Moving Average

CYTK Makes Bullish Cross Above Critical Moving Average

In trading on Friday, shares of Cytokinetics Inc crossed above their 200 day moving average of $8.26, changing hands as high as $8.45 per share. Cytokinetics Inc shares are currently trading up about 3.4% on the day.

Cytokinetics Enters Oversold Territory (CYTK)

Cytokinetics Enters Oversold Territory (CYTK)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of February 2019 Options Trading For Cytokinetics (CYTK)

First Week Of February 2019 Options Trading For Cytokinetics (CYTK)

Investors in Cytokinetics Inc saw new options begin trading this week, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Noteworthy Monday Option Activity: CYTK, NXST, TIVO

Noteworthy Monday Option Activity: CYTK, NXST, TIVO

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cytokinetics Inc , where a total volume of 1,411 contracts has been traded thus far today, a contract volume which is representative of approximately 141,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 58.4% of CYTK's average daily trading volume over the past month, of 241,790 shares.

Cytokinetics is Now Oversold (CYTK)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of November 16th Options Trading For Cytokinetics (CYTK)

First Week of November 16th Options Trading For Cytokinetics (CYTK)

Investors in Cytokinetics Inc saw new options become available this week, for the November 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Cytokinetics Names Robert Califf, M.D., To Board Of Directors

Cytokinetics Names Robert Califf, M.D., To Board Of Directors

Appointment Strengthens Regulatory, Global Clinical Research and Cardiology Expertise as Company Advances Its Development Pipeline and Executes Against Its Vision 2020

First Week of August 2018 Options Trading For Cytokinetics (CYTK)

First Week of August 2018 Options Trading For Cytokinetics (CYTK)

Investors in Cytokinetics Inc saw new options begin trading this week, for the August 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting CYTK Put And Call Options For January 2018

Interesting CYTK Put And Call Options For January 2018

Investors in Cytokinetics Inc saw new options begin trading this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CYTK options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers

Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers

The South San Francisco, Calif.-based firm said its Phase 3 study of tirasemtiv in patients with amyotrophic lateral sclerosis did not achieve primary or secondary endpoints.

TheStreet Quant Rating: D (Sell)